GeminIQ Website Logo

Viewing AMRN free

Subscribe for full history, 50+ metrics, screener, watchlist...

AMARIN CORP PLC\UK

AMRN

Companies in Pharmaceutical Preparations

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
131135123148120121157216214199271233
Restricted Cash And Cash Equivalents At Carrying V…
000000111111
Short Term Investments
17716816415116217314991941215080
Accounts Receivable Net Current
108127127119107122113124116134122123
Inventory Net
184196185171159166224239255259254227
Prepaid Expense And Other Assets Current
2624291725137328121943
Assets Current
626650628607573595650702688725718706
Property Plant And Equipment Net
-00000000000
Long Term Investments
-----------0
Inventory Noncurrent
-094057657471747892122
Operating Lease Right Of Use Asset
667888888899
Other Assets Noncurrent
111111111112
Finite Lived Intangible Assets Net
131314151616171819192020
Assets
646671660670656685751800790832839860
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
484537454640415468535354
Contract With Customer Liability Current
--------2222
Liabilities Current
180194182186162180202231224259267271
Liabilities Noncurrent
Contract With Customer Liability Noncurrent
--------2333
Operating Lease Liability Noncurrent
667788888999
Other Liabilities Noncurrent
111112121212999977
Liabilities
196211201205182199219248244280286291
Stockholders Equity
Common Stock Value
314310310309308305305305305303302302
Additional Paid In Capital
1,9221,9241,9221,9211,9161,9151,9111,9071,9031,8991,8951,892
Treasury Stock Value
-69-67-67-67-66-65-65-65-65-64-64-63
Retained Earnings Accumulated Deficit
-1,718-1,707-1,706-1,698-1,684-1,669-1,620-1,595-1,596-1,586-1,581-1,561
Stockholders Equity
449459459465474486531552546552553569
Liabilities And Stockholders Equity
646671660670656685751800790832839860
Common Stock Par Or Stated Value Per Share
0.50.50.50.50.50.50.50.50.50.50.50.5
Common Stock Shares Issued
222121212121212121212121
Shares Outstanding
212121212121212121202020
Treasury Stock Common Shares
111111111000

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20260.98%12.18%-2.45%---------
202513.85%54.32%51.18%6.75%2.54%31.20%-2.56%-17.91%-12.08%3.73%2.73%3.59%
20241.19%-17.86%-7.14%-7.35%-13.24%-14.71%-8.33%-23.33%-6.67%0.00%36.37%44.88%
2023-12.50%-16.18%-17.65%-15.13%-21.85%-36.97%11.43%30.00%50.00%-19.63%-19.63%-18.69%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
3.48
3.34
3.45
3.26
3.53
3.31
3.23
3.04
3.07
2.80
2.69
2.61
Quick Ratio
2.32
2.21
2.27
2.25
2.39
2.32
2.08
1.87
1.89
1.75
1.66
1.61
Working Capital
446.37M
455.42M
446.10M
420.87M
410.65M
415.45M
448.66M
471.30M
463.55M
465.70M
450.82M
435.56M
Leverage & Debt
Debt to Equity
0.44
0.46
0.44
0.44
0.38
0.41
0.41
0.45
0.45
0.51
0.52
0.51
Interest Coverage TTM
-5.72
-6.06
-11.65
-12.46
-9.98
-9.15
-4.40
-4.09
-6.65
-8.01
-8.57
-9.38
Debt Ratio
0.30
0.32
0.30
0.31
0.28
0.29
0.29
0.31
0.31
0.34
0.34
0.34
Efficiency & Turnover
Asset Turnover TTM
0.33
0.32
0.32
0.30
0.30
0.30
0.30
0.32
0.34
0.36
0.37
0.38
Days Sales Outstanding TTM
180.84
212.79
193.14
202.02
189.68
204.24
177.97
169.85
163.81
157.31
139.11
140.55
Receivables Turnover TTM
2.02
1.72
1.89
1.81
1.92
1.79
2.05
2.15
2.23
2.32
2.62
2.60
Per Share Metrics
Diluted EPS TTM
-1.60
-1.87
-4.15
-5.00
-4.25
-4.00
-1.91
-1.63
-2.57
-2.90
-2.57
-1.88
Free Cash Flow Per Share TTM
1.22
0.32
-1.05
-0.56
-1.49
-1.51
-0.89
-0.42
0.06
0.34
0.44
-0.81
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
52.37%
56.57%
38.87%
37.47%
34.85%
35.60%
56.46%
56.51%
53.89%
53.94%
57.07%
62.69%
Operating Profit Margin TTM
-20.64%
-23.48%
-42.50%
-50.34%
-44.35%
-40.15%
-18.30%
-15.26%
-23.01%
-22.02%
-22.43%
-16.18%
Net Profit Margin TTM
-15.51%
-18.16%
-38.01%
-47.22%
-41.07%
-35.95%
-16.32%
-12.66%
-18.96%
-19.26%
-16.27%
-11.06%
Growth Metrics
Net Revenue Growth (1Y)
1.24%
-6.55%
-5.93%
-17.15%
-22.83%
-25.51%
-25.25%
-23.53%
-23.04%
-16.87%
-23.85%
-27.19%
Net Income Growth (1Y)
-61.77%
-52.79%
119.06%
209.01%
67.15%
39.03%
-25.02%
-12.48%
-42.00%
-44.13%
-42.94%
-61.69%
EPS Growth (1Y)
-62.29%
-53.25%
116.75%
206.30%
65.82%
37.92%
-25.52%
-13.12%
-42.56%
-45.02%
-43.47%
-62.59%
Valuation Metrics
P/E TTM
-9.01
-7.47
-3.95
-3.24
-2.12
-2.45
-6.58
-8.46
-6.94
-6.00
-7.16
-12.67
P/B TTM
0.67
0.63
0.74
0.72
0.39
0.41
0.49
0.51
0.67
0.64
0.68
0.85
P/S TTM
1.40
1.36
1.50
1.53
0.87
0.88
1.07
1.07
1.32
1.16
1.17
1.40
Market Cap
302.98M
289.66M
340.32M
336.14M
186.04M
201.36M
259.02M
283.49M
365.03M
354.66M
375.74M
485.34M
Enterprise Value
171.91M
155.00M
217.52M
188.26M
66.52M
80.32M
102.08M
67.56M
151.09M
155.41M
104.93M
252.34M
Calculated Values
Free Cash Flow TTM
25.58M
6.73M
-21.86M
-11.52M
-30.88M
-31.02M
-18.36M
-8.67M
1.29M
6.88M
9.08M
-16.47M
Net Debt
-131.06M
-134.66M
-122.80M
-147.88M
-119.52M
-121.04M
-156.94M
-215.92M
-213.94M
-199.25M
-270.81M
-233.00M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2024-08-02Purchase
Owner: Berg, Aaron
Title: President and CEO
Shares: 160,000
Price/Share: $0.64
Value: $102,400.00
Shares Owned: 805,380
Relationship: Officer
Ownership: Direct
2024-01-22Purchase
Owner: Holt, Patrick
Title: President and CEO
Shares: 14,426
Price/Share: $1.09
Value: $15,724.34
Shares Owned: 314,426
Relationship: Director,Officer
Ownership: Direct
2023-12-12Sale
Owner: Ketchum, Steven B
Title: Chief Scientific Officer
Shares: 34,131
Price/Share: $0.79
Value: $26,963.49
Shares Owned: 566,100
Relationship: Officer
Ownership: Direct
2023-08-16Purchase
Owner: Holt, Patrick
Title: President and CEO
Shares: 300,000
Price/Share: $1.04
Value: $312,000.00
Shares Owned: 300,000
Relationship: Director,Officer
Ownership: Direct
2022-06-13Purchase
Owner: Wold, Olsen Per
Title: -
Shares: 55,000
Price/Share: $1.69
Value: $92,950.00
Shares Owned: 149,000
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

No institutional ownership data available.

AMARIN CORP PLC\UK (AMRN) — SEC Financial Statements & Analysis

AMARIN CORP PLC\UK (AMRN) is a pharmaceutical preparations company, incorporated in X0. AMARIN CORP PLC\UK trades on AMRN: Nasdaq as: AMRN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), AMARIN CORP PLC\UK reported a 1.24% year-over-year revenue growth, a Gross Profit Margin of 52.37% (TTM), a Debt-to-Equity ratio of 0.44x, a Price-to-Sales (P/S) ratio of 1.40x (TTM), a Price-to-Book (P/B) ratio of 0.67 (TTM), at a market cap of $302.98M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
1.24%
Gross Profit Margin TTM
52.37%
Debt To Equity
0.44x
P/S TTM
1.40x
P/B TTM
0.67
Market Cap
$302.98M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is AMARIN CORP PLC\UK in?

AMARIN CORP PLC\UK (AMRN) operates in the Pharmaceutical Preparations industry.

What is AMRN's market cap?

AMARIN CORP PLC\UK (AMRN) has a market capitalization of $302.98M as of 2026-03-31.

What exchange does AMRN trade on?

AMARIN CORP PLC\UK (AMRN) trades on the AMRN: Nasdaq.

Where is AMARIN CORP PLC\UK incorporated?

AMARIN CORP PLC\UK is incorporated in United Kingdom.

Research Faster.
Invest Smarter.

AMARIN CORP PLC\UK (AMRN) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.